News Search

Category: Uncategorized

New Proposed Federal Guidelines Could Threaten Innovation

Recently proposed guidance could expand "march-in rights" under the Bayh-Dole Act, significantly impacting the development of products from federally funded research.

The Penn Center for Innovation announces two key appointments to expand and enhance institution-wide innovation and technology commercialization activities

The Penn Center for Innovation (PCI) has announced two key appointments to support the next phase of its comprehensive innovation and commercialization plan.

Commercialization Speaker Series Engages Penn Faculty, Researchers, and Students  

The the Penn Center for Innovation, along with Penn Engineering and Penn Medicine, presented speaker sessions with experts in the field.

PCI Attends Tech Connect World Innovation Conference 2023 

From June 19-20, PCI attended 2023 Tech Connect World Innovation Conference and Expo, an annual event that brings together the creators of breakthrough technologies with corporations.

Meet the 2023/2024 PCI Fellows Cohort

Eleven fellows were admitted to the 2023/2024 cohort out of a large application pool.

Canberra IP and VL Navigator work together to improve the process of finding University available technologies on Inteum Technology Publisher

Canberra IP will now link to Visible Legacy (VL) Navigator to Search, Navigate, and Connect with context to facilitate and speed up communication with a university licensing office and inventors.

PCI Tech Publisher Site Now Has Subscription Feature

The PCI Technology Publisher website recently added a new subscription feature so that you can receive email updates about new technologies from particular inventors, categories, and departments.

Meet Our 2021/2022 PCI Fellows Graduates

Our PCI Fellows graduates are thriving in careers in IP law, mechanical engineering, life sciences investment, and more.

Tadataka “Tachi” Yamada, MD, PhD

Dr. Yamada had a distinguished career as a visionary leader in the life sciences industry. He led research and development at Takeda Pharmaceutical Co. and GlaxoSmithKline.

Meet the 2022/2023 PCI Fellows Cohort

Twelve fellows were admitted to the 2022/2023 cohort out of a large application pool. We also have three returning Sr. fellows from last year.


Skip to content